RxDoctor Payments Data

Ramon Garcia, MD

Psychiatry · Sacramento, CANPI 1063410678

Payments from drug & device makers

$371in general payments, 2019–2025

Across 12 payments — averaging $30.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$131
  • Otsuka America Pharmaceutical, Inc.$78
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$59
  • Sunovion Pharmaceuticals Inc.$50
  • Johnson & Johnson$31
  • Alkermes, Inc.$22

What the payments were for

  • Food & beverage$17848%
  • Education$19352%

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$371 in reported general payments places this provider in the 60th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$250,360
Medicare patients
325
Services billed
3,284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate264$933,421
AustedoDeutetrabenazine112$641,515
Invega TrinzaPaliperidone Palmitate53$505,915
RexultiBrexpiprazole104$152,236
Clozapine1,822$125,480
IngrezzaValbenazine Tosylate13$111,071
FanaptIloperidone30$66,027
Abilify MaintenaAripiprazole22$65,253
Olanzapine1,874$47,030
Lurasidone Hcl314$40,828
Clozapine OdtClozapine185$31,390
Perphenazine546$28,070
EmsamSelegiline12$26,488
VivitrolNaltrexone Microspheres11$18,460
Aripiprazole270$18,046

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza$31$1,439,336317 claims
Teva Pharmaceuticals USA, Inc.Austedo$131$641,515112 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$78$217,488126 claims
Alkermes, Inc.Vivitrol$22$18,46011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →